Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Pharma & Chem Co., Ltd. (HZPH) is a prominent Chinese manufacturer and supplier of active pharmaceutical ingredients (APIs), chemical intermediates, and fine chemicals. Established in 1992 and headquartered in Hangzhou, the company operates a technical research institute and multiple manufacturing facilities to serve the life science, agricultural, and industrial sectors. HZPH is particularly recognized for its production of cyclodextrins, topiramate, and various antineoplastic and antiviral intermediates. The company provides custom synthesis and contract manufacturing services to a global client base across more than 100 countries. HZPH maintains ISO 9001:2015 certification and adheres to international quality standards such as ICH Q7A for its pharmaceutical-grade products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Pharma.